The picks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The picks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sam Armstrong who wrote (4284)	2/8/1997 9:07:00 AM
From: Amigo Mike	of 6124

My picks and options: EMC recommendation: I was not able to get into the Feb 35 calls as the market opened too strong. I expected to buy @ less than 1 3/8. Opened @ 1 11/16. EMC current PE is only 22 (???) and is expected to grow earnings at least 25% this year which puts the "look ahead" PE at only 16. EXTREMELY low for EMC. This stock is a buy with minimum target of $48. Those who are conservative should buy the stock. I am searching for a new entry point in the options. HD options: I sold my Feb 50 calls two days ago. Unfortunately could have made a ton more by Friday as these options had a bid of 2 3/4 during the day. Not bad of you bought when I did @ 7/8. Looking for new entry point for expected move to $58. I posted CYRX options also: Feb 25 calls. Have traded out of these also. Will be publically announcing with COMPAQ in late Feb new Cyrix based PC for less than $1000. Target here is near $32. This one is not for the faint of heart. New entry point to follow. Currently researching for more winning options. Will post when found. Anyone else who has any option recommendations, I most certainly would enjoy hearing from you. Shawn's IOM target of $16.26, if it makes it there, looks to be a good option entry point if in fact institutional buy programs will kick in below that point. ANTX: This stock is a buy with a current ask of .93. I expect a move above $2 in the near term. At least 2 announcements are pending. One involves trial results, one is year earnings. Antex Biologics is developing vaccines for for disorders caused by bacteria. The company has deals with SKB, US Navy, Pasteur-Merioux and the National Institute of Health. To BIG vaccines they are working on are for diarrhea and children's ear infections. As far as the diarrhea vaccine goes, they have developed a vaccine that can be taking in tablet form. THIS IS VERY BIG. The ear infection vaccine is big also as there are millions of cases in the US each year. Those of you with children I'm sure have at one time or another experienced this. If anyone would like more info on ANTX, send me an email with any ???? you may have. Short term target is over $2. Longer term target is $7. There is a thread here on SI, but it is dormant. Good info there for initial research. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next